Company Presentation • 13 Sep 2022 05:00
Company Presentation • 11 Apr 2024 05:15
Company Presentation • 23 Mar 2023 20:00
Company Presentation • 11 May 2023 19:00
Company Presentation • 16 Jun 2023 19:00
Search or
𝛼SK
𝛼SKENTITY
Alpine Immune Sciences (ALPN US)
Alpine Immune Sciences (ALPN US)
1
Analysis
Health Care • United States
Alpine Immune Sciences, Inc. (AIS) focuses on developing novel protein-based cancer immunotherapies using its proprietary variant ig domain (vIgD) platform technology. The Company develops TIP technology, based on the vIgD platform, to enhance engineered cellular therapies. AIS offers a platform to interact with multiple targets, including many present in the immune synapse.
morex